CDC ENTEBBE

Pfizer and BioNTech receive FDA approval for Omicron KP.2-adapted COVID-19 vaccine for individuals 12 years and older, with emergency use authorization for those 6 months through 11 years. The vaccine is based on mRNA technology and will be available in pharmacies, hospitals, and clinics across the U.S.

Tecovirimat did not improve clade I mpox resolution in DRC, but showed safe use and lower mortality. Ongoing trials like PALM007 and STOMP aim to develop effective mpox interventions.

Mount Sinai team created a dataset and POND dashboard using NHANES data to personalize interventions for youth prediabetes and diabetes, identifying 27 risk-associated variables.